| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_93c45a43d96e1bd2581211ced18a416d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_620ecb9324409347c27e96b6071503ee |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-465 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07G99-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P1-06 |
| filingDate |
1993-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45ffd3cc65cd7d878bb7b08dae7cc405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cffdb2e8a5e9f7ad5b89a25fb6eaf8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e77263016202a18cea3dd0e11acb841
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a32ac0935c4249bd9759e182e06a45ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe7a83d38474e416e18fa182af9e4d99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1d9025dd25baa942b39eb228afda3c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dabc1b2940dc40a41f1b137d6fcf0f64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ade492b1abf07920e5eb478c7396ec1c |
| publicationDate |
1994-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H06340686-A |
| titleOfInvention |
Q-18627-A and B compounds and process for their production |
| abstract |
(57) [Summary] [Structure] Q-1 specified by the following physicochemical properties 8627-A and / or B compound Q-18627-A compound: Property: White solid molecular formula: C 32 H 48 N 2 O 7 Molecular weight: 572 Infrared absorption spectrum: Fig. 1 (potassium bromide tablet) Ultraviolet absorption spectrum: Fig. 2 (In methanol) Nuclear magnetic resonance spectrum 1 H-NMR: FIG. 3 (in deuterated chloroform, 500 MH z) 13 C-NMR: FIG. 4 (125 MH in deuterated chloroform). z) Q-18627-B compound: Molecular formula: C 31 H 46 N 2 O 7 Molecular weight: 558 Infrared absorption spectrum Fig. 5 (potassium bromide tablet) Ultraviolet absorption spectrum Fig. 6 (in methanol) Nuclear magnetic resonance spectrum 1 H-NMR : Fig. 7 (500MH in deuterated chloroform) z) 13 C-NMR: FIG. 8 (125 MH in deuterated chloroform. z) [Effect] It has a CCKB receptor antagonistic action and can be used as a central nervous system drug or a gastrointestinal drug. |
| priorityDate |
1993-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |